← Back to Search

Transplant Optimization Program for Blood Cancer

N/A

Waitlist Available

Led By Anthony Sung, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-80 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will test whether a research-based pre- and peri-transplant optimization program can improve physical, cognitive, mental, and dietary health for patients undergoing hematopoietic stem cell transplantation.

Who is the study for?

This trial is for adults aged 18-80 planning to undergo a stem cell transplant for blood cancer or other illnesses within the next 6 months. Participants must be able to exercise and have someone who can read and follow instructions in English if they cannot.Check my eligibility

What is being tested?

The R-PPOP study tests a program designed to boost health before and during stem cell transplants. It includes interval training, diet evaluation, social work support, and psychiatric consultations to improve physical, cognitive, mental health, and nutrition.See study design

What are the potential side effects?

Since this trial involves non-drug interventions like exercise and dietary changes rather than medications, side effects may include typical exercise-related issues such as muscle soreness or fatigue. Psychological support might bring emotional responses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of subjects who complete at least half of their high intensity interval training sessions

Secondary outcome measures

Assessing falls

Caregiver quality of life as assessed by the Caregiver Strain questionnaire

Caregiver support as assessed by the caregiver strain index questionnaire

+28 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: PatientExperimental Treatment4 Interventions

These are patients undergoing hematopoetic stem cell transplant. Patients will complete Interval training, undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.

Group II: CaregiverExperimental Treatment3 Interventions

These are the assigned caregivers for transplant patients. Caregivers will undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Interval training

2011

N/A

~400

0 / 1Eligibility criteria met